Colorectal cancer molecular typing marker as well as related products and application thereof

• Main Authors: GAN WENQIANG, ZHANG RIXIN, YAN ZHENG, HOU YUFANG, ZENG ZIFAN, YANG MIN, WANG WEIQI, LI TIEGANG, LYU SILIN
• Format: Patent
• Language: Chinese; English
• Published: 23.05.2023
• Subjects: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention discloses a colorectal cancer molecular typing marker as well as a related product and application thereof, the colorectal cancer molecular typing marker is PLXNC1, the product comprises a reagent for detecting the expression level of PLXNC1, and the product can be used for accurately diagnosing and distinguishing the molecular typing of the colorectal cancer of a subject. The colorectal cancer molecular typing marker has extremely high clinical application value, and provides important reference for clinical doctors to select individualized treatment schemes and realize accurate individualized treatment. 本发明公开了一种结直肠癌分子分型标志物及其相关产品和用途，所述结直肠癌分子分型标志物为PLXNC1，所述产品包含检测PLXNC1表达水平的试剂，该产品可用于准确诊断区分受试者结直肠癌的分子分型，所述结直肠癌分子分型标志物具有极高的临床应用价值，为临床医生选择个体化的治疗方案、实现精准的个体化治疗提供了重要的参考。